Vaxcyte Balance Sheet Health
Financial Health criteria checks 6/6
Vaxcyte has a total shareholder equity of $1.2B and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $1.4B and $167.4M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$1.08b |
| Equity | US$1.24b |
| Total liabilities | US$167.45m |
| Total assets | US$1.41b |
Recent financial health updates
Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans
Dec 27
We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely
Sep 12Here's Why We're Not Too Worried About Vaxcyte's (NASDAQ:PCVX) Cash Burn Situation
May 30We Think Vaxcyte (NASDAQ:PCVX) Can Afford To Drive Business Growth
Dec 22Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans
Aug 05Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans
Feb 25Recent updates
Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans
Dec 27We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely
Sep 12Here's Why We're Not Too Worried About Vaxcyte's (NASDAQ:PCVX) Cash Burn Situation
May 30We Think Vaxcyte (NASDAQ:PCVX) Can Afford To Drive Business Growth
Dec 22Vaxcyte appoints new CBO, CMO
Oct 11Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans
Aug 05Vaxcyte completes enrollment in phase 2 portion of study of pneumonia vaccine candidate
Jul 12Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans
Feb 25We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely
Nov 08We're Interested To See How Vaxcyte (NASDAQ:PCVX) Uses Its Cash Hoard To Grow
Jul 26We're Interested To See How Vaxcyte (NASDAQ:PCVX) Uses Its Cash Hoard To Grow
Apr 12Financial Position Analysis
Short Term Liabilities: PCVX's short term assets ($1.1B) exceed its short term liabilities ($145.3M).
Long Term Liabilities: PCVX's short term assets ($1.1B) exceed its long term liabilities ($22.1M).
Debt to Equity History and Analysis
Debt Level: PCVX is debt free.
Reducing Debt: PCVX has no debt compared to 5 years ago when its debt to equity ratio was 5.3%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: PCVX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: PCVX has sufficient cash runway for 2.9 years if free cash flow continues to reduce at historical rates of 40.9% each year.